Home > Name List By 5 > 5,8,11,14,17-Eicosapentaenoicacid, (5Z,8Z,11Z,14Z,17Z)- Canada

CAS No 10417-94-4 , 5,8,11,14,17-Eicosapentaenoicacid, (5Z,8Z,11Z,14Z,17Z)- Search by region : Canada

  • Name: 5,8,11,14,17-Eicosapentaenoicacid, (5Z,8Z,11Z,14Z,17Z)-
  • Synonyms: Incromega E 7010SR; Timnodonic acid;5,8,11,14,17-Eicosapentaenoicacid, (5Z,8Z,11Z,14Z,17Z)-; (all-cis)-5,8,11,14,17-Eicosapentaenoic acid; (all-Z)-D5,8,11,14,17-Eicosapentaenoicacid; Icosapentaenoic acid;5,8,11,14,17-Eicosapentaenoicacid (6CI); (5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoicacid;Ropufa 70; EPA 45G; (all-Z)-5,8,11,14,17-Eicosapentaenoic acid;Eicosapentaenoic acid; 5,8,11,14,17-Eicosapentaenoic acid, (all-Z)- (8CI); Icosapent; EPA;
  • CAS Registry Number:
  • Transport: UN 3265
  • Density: 0.941 g/cm3
  • Refractive index: n20/D 1.4977(lit.)
  • Safety Statements: 26-36/37/39-45
  • Hazard Symbols: C: Corrosive;
  • Molecular Weight: 302.45
  • InChI: InChI=1/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-
  • Risk Statements: 34
  • Molecular Formula: C20H30 O2
  • Molecular Structure:CAS No:10417-94-4 5,8,11,14,17-Eicosapentaenoicacid, (5Z,8Z,11Z,14Z,17Z)-

Related products

Select to

10417-94-4 EICOSAPENTAENOIC ACID (EPA)

  • Canada TLC PharmaChem., Inc. [Manufacturer]
  • Tel: 905-760-1098
  • Fax: 905-760-2098
  • Address: TLC PharmaChem., Inc.
    5-150 Connie Crescent
    Concord, Ontario
    L4K 1L9, Canada null,nullCanada
Contact Supplier

Select to

1/1
References of 5,8,11,14,17-Eicosapentaenoicacid, (5Z,8Z,11Z,14Z,17Z)-
Title: Eicosapentaenoic Acid
CAS Registry Number: 10417-94-4
CAS Name: (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid
Synonyms: (all-Z)-5,8,11,14,17-eicosapentaenoic acid; all-cis-fatty acid 20:5 omega-3; EPA; icosapent
Molecular Formula: C20H30O2
Molecular Weight: 302.45
Percent Composition: C 79.42%, H 10.00%, O 10.58%
Literature References: Important polyunsaturated fatty acid of the marine food chain that serves as a precursor for the prostaglandin-3 and thromboxane-3 families. It differs from arachidonic acid, q.v. (the eicosatetraenoic acid that is a precursor for the prostaglandin and thromboxane-2 families) by the extra double bond between the third and fourth carbons from the "methyl end" of the molecule. Isoln from cod liver oil: E. Klenk, D. Eberhagen, Z. Physiol. Chem. 307, 42 (1957). Enzymatic conversion to prostaglandin E3: S. Bergstr?m et al., J. Biol. Chem. 239, PC 4006 (1964). Effects on role of platelets in thrombosis: K. C. Srivastava et al., Biochem. Exp. Biol. 16, 317 (1980). Effects on prostacyclin-like material in human umbilical vasculature: J. Dyerberg, K. A. Jorgensen, Artery 8, 12 (1980). A possible relationship between diets rich in EPA in marine oils and low rates of ischemic heart disease has been proposed: H. O. Bang et al., Am. J. Clin. Nutr. 33, 2657 (1980); J. Dyerberg, Philos. Trans. R. Soc. London Ser. B 294, 373 (1981). Clinical evaluation of lipid lowering effect: Y. Nagakawa et al., Atherosclerosis 47, 71 (1983); of use in rheumatoid arthritis: J. M. Kremer et al., Ann. Intern. Med. 106, 497 (1987); of use in Raynaud's phenomenon: R. A. DiGiacomo et al., Am. J. Med. 86, 158 (1989).
Properties: Colorless oil. nD20 1.49865.
Index of refraction: nD20 1.49865
 
Derivative Type: Ethyl ester
CAS Registry Number: 86227-47-6
Trademarks: Epadel (Mochida)
Molecular Formula: C22H34O2
Molecular Weight: 330.50
Percent Composition: C 79.95%, H 10.37%, O 9.68%
 
Therap-Cat: Antilipemic.
Keywords: Antilipemic.